SK151397A3 - New pharmacological use of aii-receptor antagonists - Google Patents

New pharmacological use of aii-receptor antagonists Download PDF

Info

Publication number
SK151397A3
SK151397A3 SK1513-97A SK151397A SK151397A3 SK 151397 A3 SK151397 A3 SK 151397A3 SK 151397 A SK151397 A SK 151397A SK 151397 A3 SK151397 A3 SK 151397A3
Authority
SK
Slovakia
Prior art keywords
formula
compound
aii
mof
receptor antagonists
Prior art date
Application number
SK1513-97A
Other languages
English (en)
Slovak (sk)
Inventor
Lars Fandriks
Anders Pettersson
Anders Aneman
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of SK151397A3 publication Critical patent/SK151397A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK1513-97A 1995-05-19 1996-05-08 New pharmacological use of aii-receptor antagonists SK151397A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9501881A SE9501881D0 (sv) 1995-05-19 1995-05-19 New pharmacological use of AII-receptor antagonists
PCT/SE1996/000602 WO1996036336A1 (en) 1995-05-19 1996-05-08 New pharmacological use of aii-receptor antagonists

Publications (1)

Publication Number Publication Date
SK151397A3 true SK151397A3 (en) 1998-08-05

Family

ID=20398385

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1513-97A SK151397A3 (en) 1995-05-19 1996-05-08 New pharmacological use of aii-receptor antagonists

Country Status (23)

Country Link
US (1) US5900428A (zh)
EP (1) EP0830131A1 (zh)
JP (1) JPH11505243A (zh)
KR (1) KR19990014905A (zh)
CN (1) CN1093761C (zh)
AU (1) AU706301B2 (zh)
BR (1) BR9608407A (zh)
CA (1) CA2219395A1 (zh)
CZ (1) CZ290155B6 (zh)
EE (1) EE03666B1 (zh)
HU (1) HUP9900227A3 (zh)
IL (1) IL118299A (zh)
IS (1) IS4597A (zh)
MX (1) MX9708557A (zh)
MY (1) MY114428A (zh)
NO (1) NO975221L (zh)
NZ (1) NZ308260A (zh)
RU (1) RU2194505C2 (zh)
SE (1) SE9501881D0 (zh)
SK (1) SK151397A3 (zh)
TW (1) TW473389B (zh)
WO (1) WO1996036336A1 (zh)
ZA (1) ZA963569B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW580397B (en) * 1997-05-27 2004-03-21 Takeda Chemical Industries Ltd Solid preparation
US6514249B1 (en) 1997-07-08 2003-02-04 Atrionix, Inc. Positioning system and method for orienting an ablation element within a pulmonary vein ostium
SE9800550D0 (sv) * 1998-02-24 1998-02-24 A & Science Invest Ab A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof
ES2559766T3 (es) * 1998-05-18 2016-02-15 Takeda Pharmaceutical Company Limited Comprimidos disgregables en la boca
DE69942777D1 (de) * 1998-07-28 2010-10-28 Takeda Pharmaceutical Leicht zerfallende feste Zubereitung
AU3408801A (en) 2000-02-18 2001-08-27 Takeda Chemical Industries Ltd Tnf-alpha inhibitors
EP1750862B1 (en) 2004-06-04 2011-01-05 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition containing irbesartan
KR20130074808A (ko) 2011-12-16 2013-07-05 한올바이오파마주식회사 스타틴계 지질저하제에 의한 근육계 부작용의 치료 또는 예방을 위한 로사르탄을 포함하는 약제학적 조성물
CN104261284B (zh) * 2014-09-18 2016-02-03 中邮建技术有限公司 一种无线基站的天线吊装装置
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
US5538991A (en) * 1994-09-14 1996-07-23 Merck & Co., Inc. Endothelin antagonists bearing 5-membered heterocyclic amides

Also Published As

Publication number Publication date
TW473389B (en) 2002-01-21
CZ290155B6 (cs) 2002-06-12
RU2194505C2 (ru) 2002-12-20
MX9708557A (es) 1997-12-31
IL118299A0 (en) 1996-09-12
WO1996036336A1 (en) 1996-11-21
HUP9900227A2 (hu) 2000-03-28
CN1184424A (zh) 1998-06-10
HUP9900227A3 (en) 2002-11-28
CN1093761C (zh) 2002-11-06
JPH11505243A (ja) 1999-05-18
EE9700309A (et) 1998-06-15
EP0830131A1 (en) 1998-03-25
SE9501881D0 (sv) 1995-05-19
CZ345497A3 (cs) 1998-03-18
BR9608407A (pt) 1998-12-29
EE03666B1 (et) 2002-04-15
AU706301B2 (en) 1999-06-10
ZA963569B (en) 1996-11-19
MY114428A (en) 2002-10-31
AU5784596A (en) 1996-11-29
CA2219395A1 (en) 1996-11-21
IL118299A (en) 2000-07-26
IS4597A (is) 1997-10-22
US5900428A (en) 1999-05-04
NO975221D0 (no) 1997-11-13
NO975221L (no) 1997-11-13
KR19990014905A (ko) 1999-02-25
NZ308260A (en) 2000-12-22

Similar Documents

Publication Publication Date Title
TW570794B (en) Pharmaceutical composition for preventing and treating gastrointestinal damage and disorders, ethanol withdrawal syndrome, or pain
JP2002537332A (ja) 内臓痛を予防及び治療するためのガバペンチン誘導体
JP2002539154A (ja) ベンゾインデンプロスタグランジンの吸入送達法
BRPI0306907B1 (pt) composição farmacêutica, que compreende valsartan e inibidor de nep ou seus sais
JP2015096530A (ja) 医薬配合剤
JPH03236315A (ja) 抗精神病薬
KR20210010956A (ko) 다발성 경화증 치료용 ｓ１ｐ 수용체 조절제
TW200831078A (en) Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats
SK151397A3 (en) New pharmacological use of aii-receptor antagonists
WO2013018837A1 (ja) 左室拡張機能改善剤
CN1356908A (zh) 包含低分子量凝血酶抑制剂及其药物前体的药用制剂
TWI391131B (zh) ３－（２，２，２－三甲基肼）丙酸鹽的新用途
JPH11507921A (ja) 新規な医薬用途
BRPI0710095A2 (pt) inibidores de renina para o tratamento de hipertensão
JP2001261555A (ja) 脳動脈中膜肥厚抑制剤
JP2010536827A (ja) ある種の炎症性障害の治療に有用なカルボニルアミノ誘導体
JPH03236330A (ja) 炎症治療剤
JP2002538105A (ja) 骨体積の増加のための天然に存在しないｅｐ１選択的アゴニストの使用
CA3215906A1 (en) Use of an orexin 2 receptor agonist for post operation recovery
JP2008222685A (ja) 廃用性骨粗鬆症の予防又は治療剤
JPH0873352A (ja) 高血圧治療剤
JPS61200917A (ja) ベタキソロールとニフエジピンとを含有する医薬組成物
WO1992001468A1 (en) Endoserine converting enzyme inhibitor or vascular twitch remedy
WO1997007806A1 (fr) Agent de prevention ou remede contre les maladies des reins
TW201729801A (zh) 協同性醫藥組合物